Dan Cato

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

PAREXEL Informatics, Inc. develops and offers technology products for drug development. The company offers solutions, that include Clinical Trial Management Systems, Medical Imaging, Interactive Voice Response Systems (IVRS), and information technology services. The company was founded in 2000 and is headquartered in Waltham, MA.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

American College of Cardiology Foundation provides cardiovascular education services. Its services include cardiac surgery, chronic angine, diabetes, geriatric cardiology and heart failure and cardiomyopathies. The company was founded by Franz Groedel, Robert P. Glover and Bruno Kisc in 1949 and is headquartered in Washington, DC.

Cato BioVentures (Cato BioVentures) is a venture capital subsidiary of Cato Research LLC founded in 1990 by Allen Cato and Lynda Sutton. The firm is headquartered in Durham, North Carolina.

Edith Wolfson Medical Center provides medical services. The private company is based in Holon, Israel.

RTP Federal Credit Union is a financial institution that operates as a credit union.

WorldCare, Inc. provides information system services. The non-profit company is based in Hollywood, FL.

Diverse Lynx LLC provides information technology staffing, consulting and clinical drug trial management services. It specializes in application development, web design and support, testing and consulting services. The company was founded in 2002 and is headquartered in Princeton, NJ.

Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC.

THREAD Research develops a virtual research platform that is used by biopharmaceutical company, contract research organization, non-profit researchers, and life science organizations. It offers patient registration website, iOS and android patient applications, research site and sponsor portals, and technical support. The company was founded by Jeff Frazier in 2005 and is headquartered in Tustin, CA.

CATO SMS engages in the research and development of oncology, cell and gene therapy, and rare treatments, which supports the small and mid-sized biotech and pharmaceutical companies. Its services include clinical trial operations, regulatory consulting, medical affairs and pharmacovigilance, strategy and consulting, data management and biostats, and preclinical and nonclinical. The company was founded in 2019 and is headquartered in Schiphol, the Netherlands.

Definitive Media Corp. engages in designing, developing, and producing prepackaged computer software. The company is headquartered in Tustin, CA.

Part of CATO SMS, allucent is a clinical research organization based in Cary, NC. Allucent specializes in providing clinical expertise and regulatory consulting services to small and mid-sized biopharma companies. The company's services include drug development, biometrics capabilities, and clinical trial operations. The company also offers a resource center with the latest articles, blogs, brochures, and videos from their experts to help clients navigate the nuances and requirements of government-funded research and achieve regulatory success. The company was founded in 2019, and the CEO is Mark A. Goldberg.

Allucent is a clinical research organization that provides comprehensive drug development solutions to small and mid-sized biotech companies. The private company is based in Cary, NC, and was founded in 2022. With over 30 years of experience in more than 60 countries, the company offers consulting, clinical operations, biometrics, and clinical pharmacology services across various therapeutic areas. Allucent's individualized partnership approach provides experience-driven insights and expertise to assist its clients in successfully navigating the complexities of delivering novel treatments to patients. Mark A. Goldberg has been the CEO of the company since 2018.